OBI-833/OBI-821
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OBI-833/OBI-821, covering 2023-11-15 to 2023-11-15. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for Recurrence [Phase 2]